Skip to main content
OpenTrials
Completed

NCT Number: NCT05881018

Investigating the Effects of Diet and Physical Activity on Esport Performance

A randomized, counterbalanced intervention study in esport players.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

German Sports University Cologne

Cologne, Germany

About this study

The study will test whether i) the consumption of two different carbohydrate drinks and ii) the performance of regular high-intensity interval training will impact esport performance and metabolic profile.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Informed consent obtained
  • Male or female aged 18-45 years
  • Healthy
  • Participants have to be part of an esport association and/or regularly participate in tournaments

Exclusion criteria

  • diabetes mellitus type 1 or 2 (T1DM or T2DM)
  • medication which impacts glucose metabolism or visual perception
  • health issues like cardiovascular diseases, severe orthopaedic conditions or neurological impairments
  • food allergies or intolerances, e.g. fructose malabsorption

Treatment and study plan

Low glycaemic index

Dietary Supplement

Diet will be supplemented with a drink containing a low glycaemic index carbohydrate

High glycaemic index

Dietary Supplement

Diet will be supplemented with a drink containing a high glycaemic index carbohydrate

Physical activity

Behavioral

Participants will include physical activity units

Primary outcomes

  1. Change in esport performance (test battery)

    Time frame: 4 weeks

    Reaction time will be measured using an esport test battery

Secondary outcomes

  1. Glucose response (continuous glucose monitor): 3h iAUC

    Time frame: 4 weeks

    The 3h incremental area under the curve (iAUC) will be used to assess glycemic response to the drink. Unit: mg/dL

  2. Glycaemic variability (continuous glucose monitor): 24h MAGE

    Time frame: 4 weeks

    The mean amplitude of glycemic excursion during 24h will be assessed as an indicator for glycemic variability. Unit: mg/dL

Sponsors and collaborators

Lead sponsor

Beneo-Institute

Industry

Collaborators

  • German Sport University, Cologne

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
May 30, 2023
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.